Cargando…
Pulmonary arterial hypertension in scleroderma: care gaps in screening
One in six patients with systemic sclerosis will develop pulmonary arterial hypertension (PAH). Screening with echocardiography and possibly pulmonary function testing (to determine the diffusing capacity of carbon monoxide) is recommended to detect PAH at a less severe stage. However, real-world sc...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461777/ https://www.ncbi.nlm.nih.gov/pubmed/28587630 http://dx.doi.org/10.1186/s13075-017-1347-4 |